https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53913 Wed 28 Feb 2024 15:58:52 AEDT ]]> Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50311 Mon 17 Jul 2023 15:51:54 AEST ]]>